✦ LIBER ✦

A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

✍ Scribed by Anthony W. Tolcher; Leonard J. Appleman; Geoffrey I. Shapiro; Alain C. Mita; Frank Cihon; Arthur Mazzu; Pavur R. Sundaresan

Book ID: 105993492
Publisher: Springer
Year: 2010
Tongue: English
Weight: 265 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1372-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose-escalation study to evalu

A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer

✍ Desar, I M E; Timmer-Bonte, J N H; Burger, D M; van der Graaf, W T A; van Herpen 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 349 KB

Open-label, clinical phase I studies of

Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer

✍ Häggman, M; Ahlgren, G; Nordle, Ö; Björk, A; Damber, J-E; Bratt, O 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 371 KB

Final survival and safety results from a

Final survival and safety results from a multicenter, open-label, phase 3b trial of erlotinib in patients with advanced nonsmall cell lung cancer

✍ David R. Spigel; Ming Lin; Vincent O'Neill; John D. Hainsworth 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

## Abstract ## BACKGROUND. Erlotinib is an orally available, reversible inhibitor of epidermal growth factor receptor (EGFR) with a proven survival advantage for patients with locally advanced or metastatic nonsmall cell lung cancer (NSCLC) who have failed a prior chemotherapy. This phase 3b, mult

The efficacy and safety of degarelix: a

The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer

✍ Laurence Klotz; Laurent Boccon-Gibod; Neal D. Shore; Cal Andreou; Bo-Eric Persso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

A phase I study of docetaxel with ketoco

A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers

✍ Wei-Peng Yong; Ling-Zhi Wang; Lai-San Tham; Chiung-Ing Wong; Soo-Chin Lee; Ross 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 370 KB

Phase I study of green tea extract in pa

Phase I study of green tea extract in patients with advanced lung cancer

✍ Scott A. Laurie; Vincent A. Miller; Stefan C. Grant; Mark G. Kris; Kenneth K. Ng 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 188 KB